Evidence map›Paper›PMID 39492700›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2024

Natural history of a newly developed calcified nodule: incidence, predictors, and clinical outcomes.

Yoichiro Sugizaki, Mitsuaki Matsumura, YuWei Chen, Takunori Tsukui, Evan Shlofmitz, Susan V Thomas, Sarah Malik, Ali Dakroub, Mandeep Singh, Doosup Shin and 12 more

Abstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yoichiro SugizakiClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Mitsuaki MatsumuraClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
YuWei ChenClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Takunori TsukuiClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Evan ShlofmitzDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Susan V ThomasDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Sarah MalikDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Ali DakroubDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Mandeep SinghDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Doosup ShinDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Matthew J GranvilleDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Jordan M BuschDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Eric H WolffDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Genie M MiragliaDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Jeffrey W MosesClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Omar K KhaliqueClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
David J CohenClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Gary S MintzClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Richard A ShlofmitzDepartment of Cardiology, St. Francis Hospital, Roslyn, NY, USA.
Allen JeremiasClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Ziad A AliClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Akiko MaeharaClinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCalcified nodules (CNs) are an increasingly important, high-risk lesion subset.

aimsWe sought to identify the emergence of new CNs and the relation between underlying plaque characteristics and new CN development.

methodsPatients who had undergone two optical coherence tomography (OCT) studies that imaged the same untreated calcified lesion at baseline and follow-up were included. New CNs were an accumulation of small calcium fragments at follow-up that were not present at baseline. Cardiac death, myocardial infarction (MI), or clinically driven revascularisation related to OCT-imaged, but untreated, calcified lesions were then evaluated.

resultsAmong 372 untreated calcified lesions, with a median of 1.5 (first and third quartiles: 0.7-2.9) years between baseline and follow-up OCTs, new CNs were observed in 7.0% (26/372) of lesions at follow-up. Attenuated calcium representing residual lipid (odds ratio [OR] 3.38, 95% confidence interval [CI]: 1.15-9.98; p=0.03); log

conclusionsNew CNs developed in untreated, lipid-containing, severely calcified lesions with a larger angiographic hinge motion (between systole and diastole), compared with lesions without CNs, and were associated with worse clinical outcomes.

Indexed as

Coronary Artery DiseaseTomography, Optical CoherenceVascular CalcificationAgedCalcinosisCoronary AngiographyCoronary VesselsFemaleHumansIncidenceMaleMiddle AgedMyocardial InfarctionPlaque, AtheroscleroticRisk FactorsTreatment Outcome

Identifiers

PMID39492700
PMCPMC11522861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.